BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 26970108)

  • 1. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD.
    Su VY; Liao HF; Perng DW; Chou YC; Hsu CC; Chou CL; Chang YL; Yen JC; Chen TJ; Chou TC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2907-2915. PubMed ID: 30275689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of gastroesophageal reflux disease risk with exacerbations of chronic obstructive pulmonary disease.
    Liang B; Wang M; Yi Q; Feng Y
    Dis Esophagus; 2013 Aug; 26(6):557-60. PubMed ID: 23301861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportion of gastroesophageal reflux symptoms in patients with chronic obstructive pulmonary disease.
    Phulpoto MA; Qayyum S; Rizvi N; Khuhawar SM
    J Pak Med Assoc; 2005 Jul; 55(7):276-9. PubMed ID: 16108509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort.
    Baldomero AK; Wendt CH; Petersen A; Gaeckle NT; Han MK; Kunisaki KM;
    Respir Res; 2020 Aug; 21(1):203. PubMed ID: 32746820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort.
    Martinez CH; Okajima Y; Murray S; Washko GR; Martinez FJ; Silverman EK; Lee JH; Regan EA; Crapo JD; Curtis JL; Hatabu H; Han MK;
    Respir Res; 2014 Jun; 15(1):62. PubMed ID: 24894541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease.
    Benson VS; Müllerová H; Vestbo J; Wedzicha JA; Patel A; Hurst JR;
    Respir Med; 2015 Sep; 109(9):1147-54. PubMed ID: 26166017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?
    Iliaz S; Iliaz R; Onur ST; Arici S; Akyuz U; Karaca C; Demir K; Besisik F; Kaymakoglu S; Akyuz F
    Respir Med; 2016 Jun; 115():20-5. PubMed ID: 27215499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gastroesophageal reflux symptoms in exacerbations of COPD.
    Rascon-Aguilar IE; Pamer M; Wludyka P; Cury J; Coultas D; Lambiase LR; Nahman NS; Vega KJ
    Chest; 2006 Oct; 130(4):1096-101. PubMed ID: 17035443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD.
    Kang J; Lee R; Lee SW
    Respir Res; 2023 Mar; 24(1):75. PubMed ID: 36906585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-month follow-up study on the preventive effect of oral lansoprazole on acute exacerbation of chronic obstructive pulmonary disease.
    Xiong W; Zhang QS; Zhao W; Ding W; Liu JM; Zhao YF
    Int J Exp Pathol; 2016 Apr; 97(2):107-13. PubMed ID: 27135904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with exacerbation in mild- to-moderate COPD patients.
    Kim JK; Lee SH; Lee BH; Lee CY; Kim do J; Min KH; Kim SK; Yoo KH; Jung KS; Hwang YI
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1327-33. PubMed ID: 27366060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.
    Chubachi S; Sato M; Kameyama N; Tsutsumi A; Sasaki M; Tateno H; Nakamura H; Asano K; Betsuyaku T;
    Respir Med; 2016 Aug; 117():272-9. PubMed ID: 27492541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung hyperinflation and functional exercise capacity in patients with COPD - a three-year longitudinal study.
    Aalstad LT; Hardie JA; Espehaug B; Thorsen E; Bakke PS; Eagan TML; Frisk B
    BMC Pulm Med; 2018 Dec; 18(1):187. PubMed ID: 30522466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.